The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of chemotherapy plus immune checkpoint inhibitors in oncogenic driven non-small cell lung cancer: A University of California Lung Cancer Consortium retrospective study.
 
Karen Kelly
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sanko; Debiopharm Group; EMD Serono; EMD Serono; Genentech; Genmab; GlaxoSmithKline; Inivata; Janssen; Lilly; Novartis; Novartis; Regeneron; Symphogen; Takeda; Targeted Oncology
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; EMD Serono; Genentech/Roche; Lilly; Merck; Regeneron
 
Shuai Chen
No Relationships to Disclose
 
Joanna B Eldredge
No Relationships to Disclose
 
David Joseph Benjamin
No Relationships to Disclose
 
Matthew C Mulroy
No Relationships to Disclose
 
Nadeem Tabbara
No Relationships to Disclose
 
John Sharp
No Relationships to Disclose
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie (Inst); Advaxis (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Genentech/Roche (Inst); Lilly (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Matthew A. Gubens
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Inivata; Sanofi/Regeneron; Takeda
Research Funding - Celgene (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); OncoMed (Inst); Trizell (Inst)
 
Jeremy P. Harris
No Relationships to Disclose
 
Megan Eileen Daly
Employment - University of California
Leadership - International Journal of Radiation Oncology Biology Physics; Practical Radiation Oncology
Consulting or Advisory Role - Boston Scientific; Triptych Health Partners
Research Funding - EMD Serono; Genentech (Inst)
Travel, Accommodations, Expenses - Boston Scientific
Other Relationship - Telesecurity Sciences/Imatex
 
Sandip Pravin Patel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Compugen; Illumina; Lilly; Nektar; Novartis
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Jason Chan
No Relationships to Disclose
 
Amy Lauren Cummings
Consulting or Advisory Role - Tempus
Research Funding - Genentech (Inst); Novartis (Inst)
 
Viola Weijia Zhu
Stock and Other Ownership Interests - TP Therapeutics; TP Therapeutics (I)
Honoraria - AstraZeneca; Blueprint Medicines; Roche/Genentech; Takeda; Xcovery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; Takeda; TP Therapeutics; Xcovery
Speakers' Bureau - AstraZeneca; Blueprint Medicines; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech; Takeda; TP Therapeutics